Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Expert Opinion on Biological Therapy|May 20, 2024
Next-generation CD40 agonists for cancer immunotherapyHampus Andersson, Barnabas Nyesiga, Tova Hermodsson, et al.Plos One|September 17, 2013
Operational implementation of LED fluorescence microscopy in screening tuberculosis suspects in an urban HIV clinic in UgandaHeidi Albert, Lydia Nakiyingi, Joseph Sempa, et al.BMC Infectious Diseases|May 17, 2011
Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopyHeidi Albert, Patrick J Ademun, George Lukyamuzi, et al.Plos One|January 5, 2011
Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in UgandaHeidi Albert, Yukari Manabe, George Lukyamuzi, et al.BMC Infectious Diseases|March 2, 2010
Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in UgandaHeidi Albert, Freddie Bwanga, Sheena Mukkada, et al.Mabs|March 26, 2024
RUBY® - a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability propertiesBarnabas Nyesiga, Mattias Levin, Anna Säll, et al.Plos One|September 17, 2013
Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in UgandaLydia Nakiyingi, John Mark Bwanika, Bruce Kirenga, et al.Journal for Immunotherapy of Cancer|November 2, 2022
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodiesKarin Hägerbrand, Laura Varas, Adnan Deronic, et al.Pageof 1